SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-059931
Filing Date
2014-08-12
Accepted
2014-08-12 16:31:14
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14166_110q.htm 10-Q 713148
2 EX-10.2 a14-14166_1ex10d2.htm EX-10.2 36629
3 EX-31.1 a14-14166_1ex31d1.htm EX-31.1 11530
4 EX-32.1 a14-14166_1ex32d1.htm EX-32.1 5629
11 GRAPHIC g141661kmi001.jpg GRAPHIC 51732
12 GRAPHIC g141661kmi002.jpg GRAPHIC 23096
  Complete submission text file 0001104659-14-059931.txt   6988493

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20140630.xml EX-101.INS 668643
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20140630.xsd EX-101.SCH 81742
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20140630_cal.xml EX-101.CAL 77858
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20140630_lab.xml EX-101.LAB 1311912
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20140630_pre.xml EX-101.PRE 743382
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20140630_def.xml EX-101.DEF 511895
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 141034339
SIC: 2834 Pharmaceutical Preparations